Joint Formulary & PAD

Pentoxifylline - Post-radiation laryngeal fibrosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Modified release tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :

Approved at DTC RSFT JUne 2025

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pentoxifylline
Indication :
Post-radiation laryngeal fibrosis
Group Name :
Keywords :
post radiation laryngeal fibrosis
Brand Names Include :
Important Information :

For specialist ENT prescribing only

Latest Additions Date From :
18 Jun 2025
Latest Additions Date To :
18 Jul 2025
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

06 Jun 25 - RSFT DTC

Approved. ENT only

Other Indications

Below are listed other indications that Pentoxifylline is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Post-radiation laryngeal fibrosis .